$241 Million is the total value of TANG CAPITAL MANAGEMENT LLC's 8 reported holdings in Q3 2016. The portfolio turnover from Q2 2016 to Q3 2016 was 100.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| CLDX | Exit | CELLDEX THERAPUETICS INC | $0 | – | -50,000 | -100.0% | -0.10% | – |
| LPCN | Exit | LIPOCINE INC | $0 | – | -260,000 | -100.0% | -0.35% | – |
| BCRX | Exit | BIOCRYST PHARMACEUTICALS INC | $0 | – | -430,000 | -100.0% | -0.54% | – |
| NKTR | Exit | NEKTAR THERAPEUTICS | $0 | – | -260,000 | -100.0% | -1.65% | – |
| Exit | MERRIMACK PHARMACEUTICALS INCnote 4.5% 7/15/20 | $0 | – | -3,500,000 | -100.0% | -1.77% | – | |
| BABA | Exit | ALIBABA GROUP HOLDING LIMITEDsponsored ads | $0 | – | -60,000 | -100.0% | -2.13% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2016-11-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| HERON THERAPEUTICS INC | 40 | Q2 2024 | 55.0% |
| LA JOLLA PHARMACEUTICAL CO | 34 | Q2 2022 | 37.1% |
| ROCKET PHARMACEUTICALS INC | 23 | Q2 2024 | 31.6% |
| ANAPTYSBIO INC | 19 | Q2 2024 | 18.4% |
| BIOMARIN PHARMACEUTICAL INC | 18 | Q3 2017 | 12.1% |
| ODONATE THERAPEUTICS INC | 17 | Q4 2021 | 69.8% |
| COHERUS BIOSCIENCES INC | 16 | Q2 2024 | 2.7% |
| RELMADA THERAPEUTICS INC | 14 | Q2 2024 | 6.2% |
| EQUILLIUM INC | 14 | Q4 2023 | 1.2% |
| ALTIMMUNE INC | 13 | Q2 2024 | 6.5% |
View TANG CAPITAL MANAGEMENT LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 3 | 2024-09-18 |
| 4 | 2024-09-18 |
| SC 13D | 2024-09-18 |
| SC 13D | 2024-09-12 |
| N-PX | 2024-08-30 |
| 13F-HR | 2024-08-14 |
| 13F-HR | 2024-05-15 |
| 13F-HR | 2024-02-14 |
| 4 | 2024-02-14 |
| 4 | 2024-02-02 |
View TANG CAPITAL MANAGEMENT LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.